WSFS
MYGN icon

Wilmington Savings Fund Society’s Myriad Genetics MYGN Stock Holding History

Wilmington Savings Fund Society’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-10,490
Closed -$220K – 398
2013
Q4 		$220K Buy
10,490
+825
+9% +$20.9K 0.01% 359
2013
Q3 		$227K Buy
9,665
+1,000
+12% +$28.4K 0.01% 356
2013
Q2 		$233K Buy
+8,665
New +$251K 0.02% 346

Other funds holding MYGN

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Wilmington Savings Fund Society's MYGN Position: Q1 2014 in Review

Wilmington Savings Fund Society sold out of Myriad Genetics (MYGN) in Q1 2014, closing a stake of 10,490 shares — an estimated $220K sold.

Wilmington Savings Fund Society first reported a position in MYGN in Q2 2013 and held it in 3 quarters. The position peaked at $233K in Q2 2013. 281 funds tracked by Wall St. Rank hold MYGN as of Q1 2014.

  • Wilmington Savings Fund Society reported no remaining Myriad Genetics position as of Q1 2014 after selling out during the quarter.
  • Wilmington Savings Fund Society sold 10,490 Myriad Genetics shares in Q1 2014, an estimated $220K.
  • Wilmington Savings Fund Society first reported a position in Myriad Genetics in Q2 2013 and held it in 3 quarters.
  • Wilmington Savings Fund Society's Myriad Genetics position peaked at $233K in Q2 2013.
  • 281 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2014.

Based on Wilmington Savings Fund Society's 13F filing for Q1 2014, filed 13 May 2014.